236 results on '"Claudia Lengerke"'
Search Results
2. Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
3. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
4. Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports
5. Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype
6. PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity
7. 1401 PLT012, a monoclonal antibody targeting CD36, unleashes anti-tumor immunity via metabolic reprogramming in tumor microenvironment
8. 836 A novel PD-L1 antibody-IL10 fusion protein, PTL011, exhibits synergized therapeutic effect in hepatocellular carcinoma mouse model
9. Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study
10. S178: A NEW HEREDITARY SYNDROME WITH SEVERE NEUTROPENIA AND NEUROLOGICAL INVOLVEMENT CAUSED BY THE AUTOSOMAL RECESSIVE COPZ1 MUTATION
11. P462: RECIPIENT SEX AND DONOR RISK GROUP INFLUENCE LEUKEMIA KINETICS IN NSG MICE
12. P750: A ZEBRAFISH MODEL FOR JAGN1-ASSOCIATED SEVERE CONGENITAL NEUTROPENIA
13. PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE
14. P1268: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGH-RISK MYELODYSPLASTIC NEOPLASMS: A RETROSPECTIVE, SINGLE-CENTER ANALYSIS
15. P1357: MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA
16. Case Report: Paraneoplastic psoriasis in thymic carcinoma
17. Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
18. GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
19. Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia
20. Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma
21. Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
22. The Laminin Receptors Basal Cell Adhesion Molecule/Lutheran and Integrin α7β1 on Human Hematopoietic Stem Cells
23. Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
24. Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis
25. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
26. Value of CT-Textural Features and Volume-Based PET Parameters in Comparison to Serologic Markers for Response Prediction in Patients with Diffuse Large B-Cell Lymphoma Undergoing CD19-CAR-T Cell Therapy
27. Modeling hematopoietic disorders in zebrafish
28. Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
29. Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
30. Novel therapeutic options in Acute Myeloid Leukemia
31. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer
32. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice
33. Using zebrafish to model erythroid lineage toxicity and regeneration
34. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
35. RNA Therapeutics for Improving CAR T-cell Safety and Efficacy
36. Plattenepithelkarzinom des Kopf-Hals-Bereichs: Palliative Systemtherapie
37. CAR-T-Zell-Therapie – personalisierte zelluläre Immuntherapie im Jahr 2022
38. Chemotherapie maligner Tumore
39. Bedeutung der klonalen Hämatopoese für hämatologische Neoplasien
40. Zerebrale Metastasen: Herausforderungen der Systemtherapie
41. Trizytopenie nach Chemotherapie bei Mammakarzinom
42. Supplementary figure 4 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
43. Supplementary figure 7-8 and Table 2 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
44. Supplementary Figure and Table Legends from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
45. Supplementary figure 9-10 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
46. Supplementary figure 6 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
47. Supplementary figure 5 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
48. Supplementary information from Transition of Mesenchymal and Epithelial Cancer Cells Depends on α1-4 Galactosyltransferase-Mediated Glycosphingolipids
49. Data from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
50. Supplementary figure 2-3 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.